Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Medical Equipment Industry Analysis

UpdatedAug 24, 2026
DataAggregated Company Financials
Companies51
  • 7D3.2%
  • 3M9.9%
  • 1Y0.1%
  • YTD8.7%

In the last week, the Medical Equipment industry is up 2.5%, with Implantica leading the way, up 8.4%. Meanwhile, Xvivo Perfusion actually underperformed within the industry, shrinking 5.1% in the last week. The industry has been flat over the past 12 months despite the gain this week. Looking forward, earnings are forecast to grow by 21% annually.

Industry Valuation and Performance

Has the Swedish Medical Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 24 Aug 2026SEK 167.3bSEK 76.2bSEK 2.3b29.5x72.2x2.2x
Wed, 22 Jul 2026SEK 148.1bSEK 73.7bSEK 1.9b28.2x77.7x2x
Fri, 19 Jun 2026SEK 137.1bSEK 73.3bSEK 1.5b31.7x92.3x1.9x
Sun, 17 May 2026SEK 134.6bSEK 73.7bSEK 2.0b28.2x65.7x1.8x
Tue, 14 Apr 2026SEK 136.3bSEK 74.5bSEK 1.7b24x78.6x1.8x
Thu, 12 Mar 2026SEK 129.0bSEK 74.5bSEK 1.7b24x75.2x1.7x
Sat, 07 Feb 2026SEK 135.9bSEK 76.4bSEK 2.0b32.3x67x1.8x
Mon, 05 Jan 2026SEK 177.5bSEK 94.0bSEK 2.5b43.8x72.3x1.9x
Wed, 03 Dec 2025SEK 177.1bSEK 94.0bSEK 2.4b41.6x72.8x1.9x
Fri, 31 Oct 2025SEK 179.9bSEK 93.7bSEK 2.3b47.6x79.3x1.9x
Sun, 28 Sep 2025SEK 177.4bSEK 93.3bSEK 1.4b49.2x127.2x1.9x
Tue, 26 Aug 2025SEK 194.4bSEK 93.5bSEK 1.4b55.1x141.1x2.1x
Thu, 24 Jul 2025SEK 196.3bSEK 93.2bSEK 1.4b45.9x139.9x2.1x
Sat, 21 Jun 2025SEK 187.1bSEK 93.4bSEK 1.5b40.8x126.3x2x
Mon, 19 May 2025SEK 188.8bSEK 93.3bSEK 2.3b33.4x83.8x2x
Wed, 16 Apr 2025SEK 172.4bSEK 91.6bSEK 2.7b28.9x64.4x1.9x
Fri, 14 Mar 2025SEK 157.1bSEK 76.5bSEK 2.5b27.8x63x2.1x
Sun, 09 Feb 2025SEK 170.7bSEK 76.0bSEK 1.8b34.1x94.9x2.2x
Tue, 07 Jan 2025SEK 157.1bSEK 74.7bSEK 1.8b29.2x86x2.1x
Thu, 05 Dec 2024SEK 153.8bSEK 74.7bSEK 1.9b27.5x83.1x2.1x
Sat, 02 Nov 2024SEK 160.8bSEK 75.1bSEK 2.0b31.5x82.4x2.1x
Mon, 30 Sep 2024SEK 182.3bSEK 74.5bSEK 3.1b24.5x58.5x2.4x
Wed, 28 Aug 2024SEK 177.9bSEK 74.5bSEK 3.3b29.8x54.2x2.4x
Fri, 26 Jul 2024SEK 171.3bSEK 74.5bSEK 3.0b28.6x56.6x2.3x
Sun, 23 Jun 2024SEK 156.9bSEK 72.8bSEK 2.6b29x59.7x2.2x
Tue, 21 May 2024SEK 164.9bSEK 73.0bSEK 2.8b28.3x59.5x2.3x
Thu, 18 Apr 2024SEK 166.7bSEK 72.3bSEK 2.6b32.1x64.9x2.3x
Sat, 16 Mar 2024SEK 163.9bSEK 72.2bSEK 2.4b31.1x67.3x2.3x
Mon, 12 Feb 2024SEK 159.0bSEK 71.7bSEK 2.3b43.7x68.1x2.2x
Wed, 10 Jan 2024SEK 175.7bSEK 71.4bSEK 1.5b41.7x114.8x2.5x
Fri, 08 Dec 2023SEK 169.4bSEK 70.6bSEK 1.5b36.3x115.7x2.4x
Sun, 05 Nov 2023SEK 150.2bSEK 69.9bSEK 1.2b30.1x122.6x2.1x
Tue, 03 Oct 2023SEK 148.4bSEK 68.7bSEK 1.1b30.7x136.9x2.2x
Thu, 31 Aug 2023SEK 155.7bSEK 68.8bSEK 1.1b30.8x141.4x2.3x
Price to Earnings Ratio

141.4x


Total Market Cap: SEK 155.7bTotal Earnings: SEK 1.1bTotal Revenue: SEK 68.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Medical Equipment Industry Price to Earnings3Y Average 88x202420252026
Current Industry PE
  • Investors are pessimistic on the Swedish Medical Equipment industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 72.2x which is lower than its 3-year average PE of 88.0x.
  • The industry is trading close to its 3-year average PS ratio of 2.1x.
Past Earnings Growth
  • The earnings for companies in the Medical Equipment industry have grown 28% per year over the last three years.
  • Revenues for these companies have grown 3.5% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market0.63%
Healthcare1.82%
Medical Equipment3.19%
Medical Equipment3.90%
Medical Supplies-0.12%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry, which is trading close to its 3-year average PE ratio of 78.7x.
    • Analysts are expecting annual earnings growth of 17.4%, which is higher than its past year's earnings decline of 5.0% per year.
  • Investors are most pessimistic about the Medical Supplies industry, although it looks like investor sentiment has improved given that it's trading above its 3-year average.
Forecasted Growth
  • Analysts are most optimistic on the Medical Supplies industry, expecting annual earnings growth of 37% over the next 5 years.
  • This is better than its past earnings growth rate of 20% per year.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 17% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
IMP A SDB ImplanticaSEK 56.509.3%
+SEK 1.4b		-21.6%PS586.2x
GETI B GetingeSEK 244.301.9%
+SEK 1.3b		17.6%PE24.9x
EKTA B ElektaSEK 56.154.8%
+SEK 974.3m		15.1%PS1.3x
SUS Surgical Science SwedenSEK 49.2031.9%
+SEK 607.2m		-54.4%PE27x
CEVI CellaVisionSEK 163.608.1%
+SEK 291.0m		-8.0%PE30.2x

Latest News

PAX
SEK 55.00
Paxman
7D
24.0%
1Y
-25.5%
IMP A SDB
SEK 56.50
Implantica
7D
9.3%
1Y
-21.6%
SUS
SEK 49.20
Surgical Science Sweden
7D
31.9%
1Y
-54.4%
Narrative Update • Aug 21

SUS: Future Returns Will Reflect Improving Margins And Priced For Failure Shares

Analysts have raised their fair value estimate for Surgical Science Sweden from SEK 40 to SEK 59, citing recent research that views the business as positioned for improvement, while the stock is described as priced for failure. What's in the News There are currently no recent public news items or key developments provided for Surgical Science Sweden in the supplied sources.
SCIB
SEK 22.00
SciBase Holding
7D
-18.5%
1Y
-37.1%
OSSD
SEK 4.03
OssDsign
7D
-4.2%
1Y
-72.3%
XVIVO
SEK 280.00
Xvivo Perfusion
7D
-0.7%
1Y
56.3%
GETI B
SEK 244.30
Getinge
7D
1.9%
1Y
17.6%
Narrative Update • Aug 03

GETI B: Strong Q2 And New Therapies Will Support Higher Confidence

Analysts have lifted the Getinge fair value estimate to SEK 300 from SEK 270, citing updated assumptions around discount rates, revenue growth, profit margins, and future P/E multiples that align with recent price target increases in Street research. What’s in the News for Getinge Getinge reported a strong Q2 2026 with good organic growth, high profitability, and solid cash flow, according to recent earnings coverage.
SIN
SEK 2.98
Solution International Nordics
7D
-14.9%
1Y
n/a
STIL
SEK 232.00
Stille
7D
-1.1%
1Y
1.8%
Analysis Article • Jul 26

Stille AB Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Investors in Stille AB ( STO:STIL ) had a good week, as its shares rose 4.6% to close at kr252 following the release of...
CRAD B
SEK 34.90
C-Rad
7D
-3.1%
1Y
5.1%
Analysis Article • Jul 24

C-Rad (STO:CRAD B) Strong Profits May Be Masking Some Underlying Issues

The market for C-Rad AB (publ)'s ( STO:CRAD B ) stock was strong after it released a healthy earnings report last week...
MCAP
SEK 566.50
MedCap
7D
3.4%
1Y
-12.7%
Analysis Article • Jul 24

MedCap AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

MedCap AB (publ) ( STO:MCAP ) just released its latest second-quarter results and things are looking bullish. It was...
CEVI
SEK 163.60
CellaVision
7D
8.1%
1Y
-8.0%
Narrative Update • Jul 21

CEVI: Fair Value View Will Balance CEO Transition And Recent Downgrade

Analysts have raised their fair value estimate for CellaVision to SEK 160 from SEK 140, citing updated assumptions for revenue growth, profit margins, and a slightly lower discount rate, even as the latest Street research reflects a Hold stance with a SEK 150 price target. What's in the News for CellaVision CellaVision appointed Steve Ferguson as the new Chief Executive Officer, with the role effective June 5, 2026.
ARJO B
SEK 28.46
Arjo
7D
2.9%
1Y
-19.9%
BACTI B
SEK 14.90
Bactiguard Holding
7D
-3.9%
1Y
-44.6%
Analysis Article • Jul 17

Bactiguard Holding AB (publ) (STO:BACTI B) Just Reported Second-Quarter Earnings And Analysts Are Lifting Their Estimates

Bactiguard Holding AB (publ) ( STO:BACTI B ) investors will be delighted, with the company turning in some strong...
EKTA B
SEK 56.15
Elekta
7D
4.8%
1Y
15.1%
2CUREX
SEK 0.60
2cureX
7D
-62.0%
1Y
-79.2%